Huang, X., Weng, X., Lin, S., Liu, Y., Luo, S., Wang, H., . . . Huang, P. (2020). Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: A cost-effectiveness analysis. BMJ Open.

Huang, Xiaoting, Xiuhua Weng, Shen Lin, Yiwei Liu, Shaohong Luo, Hang Wang, Wai-kit Ming, and Pinfang Huang. "Half-dose Fulvestrant Plus Anastrozole As a First-line Treatment for Hormone Receptor-positive Metastatic Breast Cancer: A Cost-effectiveness Analysis." BMJ Open 2020.

Huang, Xiaoting, et al. "Half-dose Fulvestrant Plus Anastrozole As a First-line Treatment for Hormone Receptor-positive Metastatic Breast Cancer: A Cost-effectiveness Analysis." BMJ Open 2020.